FASLG and metabolic dysfunction-associated steatohepatitis: Recently Heikenwälder’s group reported that blocking CD95L could prevent auto-aggression of hepatocytes by CD8pos T cells in the precancerous context of Non-alcoholic steatohepatitis (NASH).